PULM

Pulmatrix, Inc.

Nasdaq · Pharmaceutical Preparations · Inc. DE · CIK 0001574235
$1.40 +1.45% $5.1M
Vol
Market Cap$5.1M
Cap SizeNano Cap
Inst. Holders8 funds
Inst. Value$291.9K
Inst. Activity1 buys / 0 sells
SEC Reports4
Exchange Nasdaq·Sector Pharmaceutical Preparations·Inc. DE·CIK 0001574235·Prev Close $1.38

Analyst Ratings

Historical distribution86% buy · 7 analysts · last covering-analyst action Aug 2023
2Strong Buy
4Buy
1Hold
0Sell
0Strong Sell
Historical Analyst Actions
DateFirmActionRating
Aug 15, 2023 HC Wainwright & Co. REITERATE Buy → Buy
May 15, 2023 HC Wainwright & Co. REITERATE Buy → Buy
Feb 7, 2023 HC Wainwright & Co. REITERATE Buy
Mar 30, 2022 HC Wainwright & Co. MAINTAIN Buy

Top Institutional Holders

FundValueMove
ROYAL BANK OF CANADA
RENAISSANCE TECHNOLOGIES LLC$140.8K
BlackRock, Inc.$70.8K
VANGUARD CAPITAL MANAGEMENT LLC$43.3K
VANGUARD FIDUCIARY TRUST CO$19.0K
8 institutional holders with $291.9K total value (226,312 shares) as of 2026-Q1. Top holders: ROYAL, RENAISSANCE, BlackRock,.

Top Institutional Holders — 2026-Q1

#FundSharesValue% of TrackedLast Move
1ROYAL BANK OF CANADA7$0.000.0%
2RENAISSANCE TECHNOLOGIES LLC109,148$140.8K48.2%
3BlackRock, Inc.54,899$70.8K24.3%
4VANGUARD CAPITAL MANAGEMENT LLC33,594$43.3K14.8%
5VANGUARD FIDUCIARY TRUST CO14,715$19.0K6.5%
6STATE STREET CORP13,945$18.0K6.2%
7Allworth Financial LP3$4.000.0%
8NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO1$1.000.0%

Recent Position Changes

FundActionPrev SharesCurr SharesChange %ValueQuarter
BANK OF AMERICA CORP /DE/DOUBLED331,365+4036.4%$3.0K2025-Q4
UBS Group AGNEAR_EXIT5,463129-97.6%$627.002025-Q3
UBS Group AGDOUBLED1,1555,463+373.0%$37.7K2025-Q2
UBS Group AGNEAR_EXIT4,9201,155-76.5%$7.7K2025-Q1
UBS Group AGDOUBLED3924,920+1155.1%$34.3K2024-Q4
BANK OF AMERICA CORP /DE/ADD3038+26.7%$81.002024-Q3

No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Historical analyst distribution (last covering-analyst action Aug 2023): 86% buy across 7 analysts — 2 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
$0.00 $0.00 $0.00 $0.0B
Next Q
$0.00 $0.00 $0.00 $0.0B
Current FY
2023-12-31
$0.00 $0.00 $0.00 $0.0B
Next FY
$0.00 $0.00 $0.00 $0.0B
1 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.

Historical Analyst Actions

DateAnalyst FirmActionPrevious RatingNew Rating
Aug 15, 2023 HC Wainwright & Co. REITERATE Buy Buy
May 15, 2023 HC Wainwright & Co. REITERATE Buy Buy
Feb 7, 2023 HC Wainwright & Co. REITERATE Buy
Mar 30, 2022 HC Wainwright & Co. MAINTAIN Buy

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
Mar 1, 20252410086%
Feb 1, 20252410086%
Jan 1, 20252410086%
Dec 1, 20242410086%
Strong BuyBuyHoldSellStrong Sell

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

May 13, 2026
earnings_calendar
PULM Q1 2026 Earnings Scheduled — 2026-05-13
May 8, 2026
earnings_calendar
PULM Q1 2026 Earnings Scheduled — 2026-05-08
Mar 26, 2026
earnings_calendar
PULM Q4 2025 Earnings Before Market Open — 2026-03-26